Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
19.42%
↓ 45% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
35.46%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 19.42% |
| Q2 2025 | -2.79% |
| Q1 2025 | 11.01% |
| Q4 2024 | 98.07% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | 99.87% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 0.00% |